Trimel Pharmaceuticals news from FierceBiotech
News
Melnyk switches focus to new company
Eugene Melnyk's decision to back away from his showdown with Biovail's management team lays the stage for him to start a new company - Trimel Biopharma. Melnyk has described the business model for Read more...
Melnyk outlines $100M blueprint for new developer
Fresh from losing an insurgent attack aimed at winning back control of Biovail, the Canadian entrepreneur says he plans to invest $50 million to $100 million of his own money to start a new R&D Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets